Zinecard OverviewDexrazoxane hydrochloride (Zinecard by Pfizer in USA and Canada; Cardioxane by Novartis for EU and other countries) is a cardioprotective agent. It was discovered by Kurt Hellmann in 1972. Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of anthracyclines, such as daunorubicin or doxorubicin. However, in July 2011 the US Food and Drug Administration released a statement restricting use only in adult patients with breast cancer who have received ...
Read more Zinecard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: http://en.wikipedia.org/wiki/Dexrazoxane
Recent Zinecard Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 250mg, 250mg/vial, 500mg, 500mg/vial